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Wound healing is a complicated biological process that involves interactions of multiple cell types, various
growth factors, their mediators, and the extracellular matrix proteins. In this study, we have studied the
differential regulation of angiogenic genes during wound healing in transgenic (Lepr /) diabetic mice and
non-diabetic mice. Under aseptic conditions, 8 mm full thickness cutaneous wounds were created on either
side of the mid-dorsal. Wound tissues were studied at 4, 7, and 11 days post-wounding and healing was assessed
by histology. The pathway-specific gene array data demonstrated differential regulation of growth factors,
transcription factors, and other related genes, such as fibroblast growth factors and their receptors. The
extracellular matrix protein osteopontin (OPN), an important component of cellular immunity and
inflammation, showed higher expression in non-diabetic wounds after 4 days post-wounding, whereas its
expression was at basal level in diabetic wounds. OPN expression remained upregulated in non-diabetic
wounds at day 7 post-wounding and was downregulated to basal level at day 11 post-wounding. However,
expression of OPN was upregulated in diabetic wounds at day 7 post-wounding and remained constitutively
higher at day 11 post-wounding. OPN expression was concomitant with the extent of healing as assessed by
histology at the corresponding sampling point. This finding suggests that OPN might be playing a crucial role in
the early events of the wound healing and its delayed expression may be in part responsible for the delayed
healing of wounds in diabetic mice.
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INTRODUCTION
Wound healing, irrespective of the way injury is caused,
proceeds via overlapping events broadly classified as
inflammation, formation of granulation tissue, angiogenesis,
and tissue remodeling (Martin et al., 1992; Suh and Hunt,
1998). Interaction of different cell types, extracellular matrix
proteins, and their receptors are involved in these biological
significant processes, which are mediated by cytokines and
growth factors (McDonald, 1989). Release and presence of
growth factors affect recruitment, activation, mitogenesis,
migration, and differentiation of various cell types in the
wound bed (Mustoe et al., 1991). Many factors affect normal
course of healing resulting in the chronic wounds. These
factors may involve infection in wound, malnutrition, poor
management of wound resulting in the hypoxia and diseased
condition of a person like diabetes, obesity, and immuno-
suppresion. Multiple factors contribute towards the impair-
ment of wound healing in diabetes. These factors include
inadequate blood supply owing to venous insufficiency and
cuffing of microvessels (Cohen et al., 1997), decreased
proliferative potential of fibroblasts (Vande Berg et al.,
1995), decreased inflammatory changes, and failure of
migrating macrophages to show activation markers (Moore
et al., 1997). A transgenic diabetic mouse, therefore, is a
good model to study diabetic impaired wound healing.
Angiogenesis, new capillary formation involving acti-
vation, migration, and proliferation of endothelial cells from
pre-existing vessels, is a fundamental process in healing multi-
ple types of injuries. Within hours of injury, degranulating
platelets release multiple chemokines including transforming
growth factor-beta (TGF-b), platelet-derived endothelial
growth factor, and vascular endothelial growth factor (VEGF).
Accompanied by the local release of histamine and serotonin
growth factors cause vasodilation and leakage of the vessels
(Liekens et al., 2001). The extravasations of the plasma
protein create a temporary support structure over which the
activated endothelial cells, leucocytes, and epithelial cells
migrate. As inflammation continues, neutrophils continue to
migrate to the wound. Neutrophils, aided by mast cells,
release mediators like histamine, proteoglycans, proteases,
platelet-activating factor, and cytokines, including TGF-b
and IL-4 (Huttunen et al., 2000). Within the granulation
tissue, angiogenesis is potentiated by hypoxia, nitric oxide,
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In this study, we have evaluated the differential regulation
of angiogenic genes involved during wound healing of
diabetic and normal mice. Our study for the first time
demonstrates the regulation of many growth factors and
cytokines during the impaired healing process in diabetic
mice as compared to the normal wound healing process. We
have utilized the gene array approach to understand the
expression pattern of the genes involved in angiogenesis
during wound healing. Tissues were collected at three time
points; 4, 7, and 11 days post-wounding. Our data
demonstrate the differential regulation of positive and
negative regulators of angiogenesis. We have reported for
the first time the differential regulation of osteopontin (OPN),
a positive regulator of angiogenesis, along with the other
genes. This result was further confirmed by reverse trans-
criptase-PCR (RT-PCR) and immunohistochemical analysis.
These findings suggest that there exist complex regulatory
pathways that are involved during the impaired wound
healing.
RESULTS
Diabetic wound exhibited delayed wound closure, prolonged
inflammation, poor angiogenesis, and less matrix deposition in
wound bed as compared to the normal wound healing
Visual observation of the wounds at the time of euthanasia
showed delayed healing in the diabetic wounds as compared
to the normal non-diabetic. Normal wounds looked healthier
as they were well contracted, not oozing, and dried unlike
many diabetic wound. Multiple serial hematoxylin and eosin
stained sections of biopsy punch tissues of the diabetic and
normal mouse were examined for epithelial regeneration,
cellular content, density of newly formed vessels in the
granulation tissue, organization of the cellular tissue at 4, 7,
and 11 days after wounding. Wound organization was
assessed in terms of number of vessels, cell types, and
collagenization in the granulation tissue. On the 4th day,
diabetic wound tissue showed poor healing progress indi-
cated by no epidermal regeneration and underlying dermis
showed higher degree of necrosis, few cells in the wound bed
most of them being inflammatory cells, no collagen depo-
sition, and no neovascularization (Figure 1a and b). Whereas
normal wound showed clearance of necrosis and more cells
in the wound bed. Newly formed epithelium was evident
in the normal wound along with initiation of collagen
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Figure 1. Masson Ttrichome staining of diabetic and non-diabetic wounds at day 4, 7, and 11 post-wounding. (a) ( 4) and (b) ( 20) Diabetic wound
shows necrosis (indicated with arrow) and inflammation as shown by arrow, few cells in the wound bed, and no re-epthelialization. (c) (4) and (d) ( 20)
Non-diabetic wound shows clearance of necrosis, re-epithelialization has initiated, and more cells are in the wound bed. Collagen deposition has initiated
and is stained in blue (indicated with arrow). (e) (4) and (f) ( 20) Diabetic wound shows clearance of necrosis, unorganized collagen deposition (indicated
with arrow). Newly formed vessels can be seen in the dermis but vessels are not well organized. (g) ( 4) and (h) ( 20) Non-diabetic wound are in advanced
stage of healing. Collagen fibers are organized, parallel to the epithelium (indicated with arrow). Vessel formation is extensive and organized towards the
epithelium. Epithelial regeneration is almost complete (indicated with arrow). (i) ( 4) and (j) (20) Diabetic wound, epithelial regeneration is complete
with multilayered epithelium (indicated with arrow). Collagen deposition is organized but less dense (indicated with arrow). The whole diabetic wound appears
fragile and wound thickness is less as compared to the non-diabetic wound. (k) ( 4) and (l) (20) Non-diabetic wound is completely healed with dense
multilayered epithelium (indicated with arrow). Thick dense fibers of collagen are organized with the epithelium and there is reduction in the number of the
blood vessels (indicated with arrow), characteristics of the late stages of healing.
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deposition and vessel formation in the underlying dermis
(Figure 1c and d).
On the 7th day, diabetic wound showed some advance in
the healing response. Epidermal regeneration had started and
the underlying dermis still showed traces of the necrotic
tissue but there were more cells, sparse collagen deposition
with few newly formed vessels. There was poor vessel
organization and collagen deposition in the wound bed
(Figure 1e and f). Normal wound at this time showed almost
complete epithelialization. Organization of the granulation
tissue was also more advanced with more cells and thick
bundles of collagen that had started to align with the
epithelium. There was extensive and organized vasculariza-
tion of the dermis with vessels being mature and aligned
perpendicular to the epithelium (Figure 1g and h).
Eleventh day showed complete closure of the diabetic
wound. Granulation tissue was fragile with more cells,
organized but not dense collagen fibers, and extensive
vascularization (Figure 1i and j). Normal wound showed
complete and mature multilayered epidermis. Granulation
tissue showed dense and thick collagen fibers. Vessels in the
granulation tissue had reduced at this time as expected
(Figure 3k and l).
Re-epithelialization, wound contraction, and angiogenesis is
inhibited in diabetic wound healing
Morphometeric analysis of the diabetic and normal wound
healing shows a delay in the epithelial migration and larger
wound gap. On the 4th day, wound width and epithelial gap
was significantly higher in the diabetic wound as compared
to the normal wound (Figures 2 and 3). There was 41%
reduction in the epithelial gap and 21% reduction in the
wound width in the normal wound as compared to the
diabetic wound. On 7th day, again there was more epithelial
gap in the diabetic wound as compared to the normal wound.
There was a significant difference in the wound gap on 11th
day between the diabetic and normal wound (Figure 2),
although there was complete epithelialization of wound in
both diabetic and normal group (Figure 3).
Angiogenesis was measured by the vessel count in the
wound tissues. On the 4th day, vessel counts were
significantly higher in the normal wound bed as compared
with the diabetic wound (Figure 4) that showed few or no
vessels in the granulation tissue. Vessel counts remained
significantly high in the normal wound on day 7 post-
wounding as compared to the diabetic wound, which
showed vascularization of the granulation tissue at that time.
On day 11, vessel counts in the normal wound decreased as
expected and the granulation tissue was more mature and
organized. Vessel counts were significantly higher in the
diabetic wound indicating active healing progressing in the
wound bed.
cDNA microarray
The angiogenic gene expression profile of wound tissue in
transgenic diabetic mice was compared with the normal mice
(Figure S1). Profiling of these genes showed differential
regulation of many angiogenic promoters, inhibitors, growth
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Figure 2. Wound contraction in diabetic and non-diabetic wound in mice.
Wound width was taken as a measure of wound contraction. It was evaluated
at the center of the wound as the gap between newly formed granulation
tissue from the edges of the wound. Diabetic wound width is more than the
normal wound all through out the experiment. Values are expressed as
mean7SEM. *Po0.05.
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Figure 3. Epithelial gap in diabetic and non-diabetic wound in mice.
Epithelial gap was measured as the distance between the two margins of the
inward growing epithelium. It is significantly more in diabetic mice at day 4
post-wounding correlating with the delayed healing in diabetic wound.
Values are expressed as 7SEM. *Po0.008.
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Figure 4. Vessel counts in diabetic and non-diabetic wound in mice. Density
of the vessels in the wound bed of diabetic and normal mice. Vascular
spaces as identified by endothelial-lined channels were counted in the
sections of the wound bed. Mean number of the blood vessels per seven fields
(40) were calculated and averaged for the group. Vessel counts were
significantly higher in the normal wounds as compared to the diabetic wound
at day 4 and day 7. At the 11th day, vessel count was significantly higher
in the diabetic wound as compared to the normal wound. Values are
expressed as mean7SEM. *Po0.05 and **Po0.006.
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factors, and cytokines, like angiopoietin 2, fibroblast growth
factor receptor, TGF-b receptor 2 and 3 (TGF-bR2 and TGF-
bR3), VEGF, midkine, secreted protein acidic and rich in
cystein, also called osteonectin, tenasin C, mammary serine
protease inhibitor and serine protease inhibitor F1 also called
pigment epithelium-derived factor, nitric oxide synthase 3
also called endothelial nitric oxide synthase, and SPP1/OPN
(Tables 1 and 2). Among all the genes stated, OPN showed
the greatest degree of differential regulation and was studied
extensively in our study. The cDNA microarray analysis
showed a delay in the OPN expression in the genetically
diabetic mice as compared to normal healthy mice. OPN
expression in diabetic mice was minimum/basal level on day
4 post-wounding that significantly increased at day 7 post-
wounding with some downregulation on day 11 post-
wounding. However, in the normal non-diabetic mice, the
expression was higher on day 4 post-wounding that remained
constitutively upregulated on day 7 post-wounding and was
downregulated to near basal level on day 11 post-wounding.
RT-PCR and immunohistochemistry of OPN
RT-PCR analysis of the RNA obtained from the wound tissues
showed differential expression of OPN (Figure 5a and b).
OPN expression increased as the wound healing progressed
in the diabetic mice. On day 4, OPN expression in diabetic
wound showed low or no expression, whereas its expression
was several folds higher in the normal wound. On day 7,
OPN expression increased in diabetic wound and there was
no significant difference between diabetic and normal wound
with respect to OPN expression. However, OPN expression
in normal wound decreased to the basal level but remained
several fold higher in the diabetic wound. OPN-specific
immunostaining in paraffin-embedded tissue section also
supported the cDNA microarray and RT-PCR findings.
Diabetic wound tissues showed low basal level expression
at day 4, its expression increased several folds by day 7, and
remained constitutively higher at day 11 post-wounding.
Whereas in the normal wound tissues OPN expression was
several fold higher on day 4, remained upregulated on day 7,
and then was downregulated to basal level on day 11
(Figure 6).
DISCUSSION
The process of wound healing is not just a local reaction but
depend on the overall condition of the afflicted person and
number of endogenous factors such as age, metabolic
condition, etc. The relationship between the wound and the
patient is complex and becomes more important when there
Table 1. Diabetic wound gene expression
UniGene
Ref. Seq.
Number Symbol Description Control Day 4 Day 7 Day 11
Mm.373514 NM_007426 Angpt2 Angiopoietin 2 586.890 372.519 267.023 183.513
Mm.18628 NM_007643 Cd36 CD36 antigen 1062.053 1270.114 739.922 761.052
Mm.21767 NM_009868 Cdh5 Cadherin 5 5538.686 991.494 812.266 708.994
Mm.276715 NM_008011 Fgfr4 Fibroblast growth factor receptor 4 171.876 298.298 250.005 123.421
Mm.193099 NM_010233 Fn1 Fibronectin 1 (A) 202.586 238.062 175.647
Mm.3879 NM_010431 Hif1a Hypoxia-inducible factor 1, alpha subunit (A) 401.464 234.523 137.667
Mm.268521 NM_010512 Igf1 Insulin-like growth factor 1 (A) (A) 182.348 209.855
Mm.906 NM_010784 Mdk Midkine 189.518 202.213 471.444 463.711
Mm.29564 NM_008610 Mmp2 Matrix metalloproteinase 2 (A) (A) 113.867 60.802
Mm.4406 NM_013599 Mmp9 Matrix metalloproteinase 9 (A) (A) 110.062 21.2445
Mm.239291 NM_031195 Msr1 Macrophage scavenger receptor 1 (A) (A) 96.947 47.286
Mm.258415 NM_008713 Nos3 Nitric oxide synthase 3, endothelial cell (A) 336.128 135.081 146.303
Mm.343951 NM_008816 Pecam1 Platelet/endothelial cell adhesion molecule (A) (A) 155.865 69.0146
Mm.268618 NM_009257 Serpinb5 Serine (or cysteine) proteinase inhibitor,
clade B, member 5
290.564 (A) 97.277 87.523
Mm.2044 NM_011340 Serpinf1 Serine (or cysteine) proteinase inhibitor,
clade F, member 1
(A) 74.322 (A) (A)
Mm.291442 NM_009242 Sparc Secreted acidic cysteine rich glycoprotein 321.141 1476.201 656.080 738.428
Mm.288474 NM_009263 Spp1 Secreted phosphoprotein 1 (A) 1368.395 683.825 794.925
Mm.26688 NM_011581 Thbs2 Thrombospondin 2 (A) (A) 132.688 138.060
Mm.980 NM_011607 Tnc Tenascin C 257.995 266.980 264.796 150.223
Mm.282184 NM_009505 Vegfa Vascular endothelial growth factor A (A) (A) 69.944 52.218
Total RNA was isolated form transgenic diabetic mice wound tissues at 4, 7, and 11 day post wounding. cDNA microarray were purchased from Superarray
Inc. and images were analyzed using GEArray Expression Analysis Suite software (SuperArray Biosciences Corp., Frederic, MD).
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is healing impairment owing to the metabolic condition of
patients. Therefore, individual condition of the organism
should certainly be more strictly put into the therapy concept.
In transgenic diabetic mice, healing is impaired due to altered
metabolic condition similar to human diabetic condition,
therefore, transgenic diabetic mice is a good model to study
impaired would healing.
In this study, which expanded for 11 days, we studied the
angiogenic gene expression profile using the cDNA micro-
array technique in both diabetic and normal wound healing
process. Profiling of these gene shows differential regulation
of many growth factors, angiogenesis modulators, and
cytokines.
Vascular endothelium in the wound is the target for the
action of angiopoietins as they are involved in the initiation,
maturation, and remodeling of the vessels (Davis et al., 1996;
Suri et al., 1996; Maisonpierre et al., 1997; Valenzuela et al.,
1999). Angiopoietin 2 is antagonistic to the tie2 receptor on
the endothelial cells and is expressed at the sites of vessel
remodeling like female reproductive tract and tumor growth,
and metastasis. It inhibits the contact between the endothelial
cells and extracellular matrix and is thought to block the
stabilization effect of the angiopoietin 1 (Davis et al., 1996;
Suri et al., 1996; Maisonpierre et al., 1997; Holash et al.,
1999). It has also been shown to be elevated in diabetic
wounds (Kampfer et al., 2001) and in early phases of ulcer
healing. In our study, angiopoietin 2 had higher expression
early in the diabetic wound as compared to the non-diabetic
wound. However, in non-diabetic wounds its expression
increased later in the healing concomitant with vessels
degeneration as expected. Higher expression pattern of
angiopoietin 2 correlates with the delayed vascularization
Table 2. Non-diabetic wound gene expression
UniGene
Ref. Seq.
Number Symbol Description Control Day 4 Day 7 Day 11
Mm.373514 NM_007426 Angpt2 Angiopoietin 2 335.553 376.069 446.947 347.604
Mm.18628 NM_007643 Cd36 CD36 antigen 249.1064 519.151 396.294 439.308
Mm.21767 NM_009868 Cdh5 Cadherin 5 794.877 451.989 516.804 556.614
Mm.982 NM_007901 Edg1 Endothelial differentiation sphingolipid G-protein-coupled receptor 1 (A) 59.928 53.624 33.308
Mm.290822 NM_010152 Erbb2 V-erb-b2 erythroblastic leukemia viral oncogene homolog 2 28.865 (A) (A) (A)
Mm.276715 NM_008011 Fgfr4 Fibroblast growth factor receptor 4 104.301 185.966 166.979 112.372
Mm.193099 NM_010233 Fn1 Fibronectin 1 58.570 188.284 254.508 259.520
Mm.3879 NM_010431 Hif1a Hypoxia-inducible factor 1, alpha subunit (A) 271.294 209.904 185.819
Mm.268521 NM_010512 Igf1 Insulin-like growth factor 1 32.101 (A) (A) 54.238
Mm.16234 NM_010577 Itga5 Integrin alpha 5 (fibronectin receptor alpha) (A) 53.084 51.322 49.791
Mm.906 NM_010784 Mdk Midkine 147.573 171.626 164.904 190.275
Mm.29564 NM_008610 Mmp2 Matrix metalloproteinase 2 78.847 125.546 261.332 361.929
Mm.4406 NM_013599 Mmp9 Matrix metalloproteinase 9 (A) 71.413 172.769 (A)
Mm.343951 NM_008816 Pecam1 Platelet/endothelial cell adhesion molecule (A) 124.359 121.868 137.120
Mm.275434 NM_008969 Ptgs1 Prostaglandin-endoperoxide synthase 1 53.146 (A) (A) (A)
Mm.241109 NM_019765 Rsn Restin (Reed-Steinberg cell-expressed intermediate
filament-associated protein)
79.774 (A) (A) 50.051
Mm.290320 NM_011333 Ccl2 Chemokine (C-C motif) ligand 2 25.805 (A) (A) (A)
Mm.268618 NM_009257 Serpinb5 Serine (or cysteine) proteinase inhibitor, clade B, member 5 198.656 (A) (A) 103.471
Mm.2044 NM_011340 Serpinf1 Serine (or cysteine) proteinase inhibitor, clade F, member 1 133.814 220.486 233.984 266.153
Mm.291442 NM_009242 Sparc Secreted acidic cysteine rich glycoprotein 908.490 635.289 545.978 251.601
Mm.288474 NM_009263 Spp1 Secreted phosphoprotein 1 (A) 506.813 668.969 62.124
Mm.172346 NM_009371 Tgfbr2 Transforming growth factor, beta receptor II 125.577 161.972 133.360 280.025
Mm.200775 NM_011578 Tgfbr3 Similar to Ornithine decarboxylase (ODC) 29.433 29.678 27.241 86.0149
Mm.26688 NM_011581 Thbs2 Thrombospondin 2 78.023 161.192 350.538 454.223
Mm.206505 NM_011594 Timp2 Tissue inhibitor of metalloproteinase 2 105.495 80.278 150.195 261.431
Mm.980 NM_011607 Tnc Tenascin C 103.680 321.554 284.781 273.393
Mm.282184 NM_009505 Vegfa Vascular endothelial growth factor A 76.428 172.394 107.788 136.973
Total RNA was isolated form wild type control mice wound tissues at 4, 7, and 11 day post wounding. cDNA microarray were purchased from Superarray
Inc. and images were analyzed using GEArray Expression Analysis Suite software (SuperArray Biosciences Corp.).
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of the underlying dermis in the diabetic wound as compared
to the non-diabetic wound.
Several independent laboratories have demonstrated that
hypoxia plays an important role in normal healing of the
wound. Hypoxic condition early in the wound results in
induction and increase of VEGF, type I collagen synthesis by
fibroblasts, and matrix metalloproteinase activity in wound
(Steinbrech et al., 1999). It promotes keratinocyte migration,
suggested to be mediated by urokinase plasminogen activator
and induces matrix metalloproteinase-9 synthesis by kerati-
nocytes (O’Toole et al., 1997). Hypoxia-inducible factor
induces transcription of genes encoding angiogenic growth
factors by hypoxic cells and hypoxia-stimulated endothelial
cells (Manalo et al., 2005). Prolonged hypoxia results in
decreased rate of wound healing owing to reduced blood
supply induced by erythrocytosis and an elevated blood
viscosity (Kivisaari and Niinikoski, 1975). It also decreases
collagen synthesis and results in prolonged and elevated
matrix metalloproteinase activity (Yamanaka and Ishikawa,
2000). In our study, hypoxia-inducible factor 1a is induced
early at day 4, in both the diabetic and non-diabetic wound.
Its expression, however, was downregulated by day 11 post-
wounding in the non-diabetic wound. The wounds in these
animals were in advanced stage of healing showing dense
and organized collagen deposition and good vascularization
of underlying dermis. Diabetic wound, however, showed
constitutively high expression all through the study and
showed prolonged necrosis, poor collagen deposition, and
delayed neovascularization of wound bed in wound tissues.
OPN, also known as early T lymphocyte activation-1, is a
secreted phosphorylated acidic glycoprotein containing a
arginine–glycine–aspartate cell-binding domain that is present
in many extracellular matrix proteins and is critical for
integrin binding (Oldberg et al., 1986; Young et al., 1990;
Patarca et al., 1993). It is synthesized by a variety of immune
and non-immune cells such as macrophages, lymphocytes,
natural killer cells, and B cells (Franzen and Heinegard,
1985; Senger and Perruzzi, 1985; Patarca et al., 1989).
Biological activity of OPN has a wide range such as
involvement in bone reabsorbtion, atheromatous plaque
formation, and dystrophic calcification of inflamed tissue
(O’regan and Berman, 2000). Although the function, anti- or
proinflammatory, of OPN in these processes is unclear, it acts
as a cytokine that plays important roles in monocyte/
macrophage functions (Denhardt et al., 2001; O’Regan
et al., 2000). OPN also acts as a survival factor for epithelial
and endothelial cells (Ophascharoensuk et al., 1999; Lin
et al., 2000) and its expression is induced in response to
hypoxia (Hampel et al., 2003; Sorensen et al., 2005; Zhu
et al., 2005).
In our study, OPN expression was concomitant with the
extent of angiogenesis and collagenization in the wound bed.
OPN expression increased with increased vessel formation
and collagen deposition in the wound bed. In diabetic
wound, lower expression of OPN at early time points was
associated with the necrosis and inflammatory condition of
the wound, whereas in the normal wound, which shows far
less inflammation and formation of new blood vessels, its
expression is several folds higher. OPN expression in diabetic
wound increased as the inflammation resolved and there was
formation of new blood vessels and collagen deposition in
the wound bed, whereas in the normal wound, showing
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Figure 5. RT-PCR for OPN mRNA in diabetic and non-diabetic wounds.
(a) Expression of OPN mRNA in diabetic and non-diabetic wounds in mice.
Total RNA was extracted from the wound tissue and 1 mg of RNA was
subjected to RT-PCR analysis. Lanes: M: DNA molecular weight marker;
1: diabetic day 4 post-wounding; 2: diabetic day7 post-wounding; 3:
diabetic day11 post-wounding; 4: non-diabetic day 4 post-wounding; 5:
non-diabetic day 7 post-wounding; 6: non-diabetic day11 post-wounding.
Equal amount of RNA in RT-PCR expression was checked by analyzing
b-actin as shown in the lower panel. This is the representative of two
experiments with similar results. (b) Quantitation of the levels of expression
of OPN mRNA in diabetic and non-diabetic wound in mice. Quantitative
estimation was performed by densitometry analysis of the PCR product shown
in Figure 5a. Values were normalized to the corresponding values of the
housekeeping genes for individual samples.
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Figure 6. Immunohistochemistry for OPN expression in diabetic and
non-diabetic wound in mice. Paraffin-embedded formalin-fixed tissue
sections were studied for OPN expression using immunohistochemistry as
described in Materials and Methods. OPN expression was low in diabetic
wound at day 4 as compared to high expression of OPN in non-diabetic
wound. OPN expression in diabetic mice increased at day 7, whereas it
remained constitutively high in the non-diabetic wound. On day 11, post-
wounding OPN expression remained constitutively high in the diabetic
wound, whereas it expression was downregulated to basal level in non-
diabetic wound. Objective used: original magnification 60.
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active angiogenesis and collagenization, its expression
remained plateued. At the end point of the study, OPN
expression is downregulated to basal level in the normal
wound, which shows mature blood vessels, orderly collagen
deposition in wound bed, and re-epitheliazation of wound.
But in the diabetic wound, where active angiogenesis and
collagen deposition are in progress, OPN expression remains
higher several folds as compared to the normal wound. OPN
knockout mice show abnormal matrix organization (Liaw
et al., 1998) and it acts as the adhesion factor for the
myeloma cells (Standal et al., 2004). OPN also binds and
stimulates migration of the endothelial cells (Hamada et al.,
2003) and induce tube formation in endothelial cells
(Hamada et al., 2003). OPN is synthesized by macrophages
as part of a generalized reaction to tissue injury (Murry et al.,
1994) and there is evidence that it may regulate macrophage
recruitment and function (Ophascharoensuk et al., 1999; Lin
et al., 2000). Our study is in consent with these observations
where OPN expression is associated with the better
angiogenesis and collagenization of wound bed. Delay in
the diabetic wound healing may be in part because of the low
expression of the OPN early in the wound bed after
wounding, which may resulted in the poor migration of
immune cells to the site of injury resulting in the accumu-
lation of the cell debris, decreased recruitment of the
endothelial cells, thus delay in angiogenesis and poor matrix
organization. OPN also interacts with the integrin family
receptors. Integrin family receptor, avb3, is involved in the
cell signaling and migration in vascular smooth muscle cells
and other cell types (Clyman et al., 1992). OPN is postulated
to have diverse function, suggesting that it might interact with
more than one type of receptor (Giachelli et al., 1995).
Integrin aV (aVb1, aVb3, aVb5, aVb6, and aVb8) mediates cell
adhesion to various matrix proteins, like fibronectin, tenas-
cin, fibrinogen, OPN etc. (Bayless et al., 1998) at sites
containing the arginine–glycine–aspartate sequence. Integrin
a6b4 activation is implicated in the proliferation of the basal
keratinocytes and possibly other cells that are in contact with
the basement membrane (Mainiero et al., 1997). Integrin
aVb6 plays role in keratinocytes migration over fibronectin
and is critical for migration over vitronectin (Huang et al.,
1998). These studies combined with our results suggest that
OPN might be interacting with the integrin receptors on the
keratinocytes and facilitating the process of re-epithelializa-
tion and wound closure.
Wound healing is a complex process, which involves a
cascade of interaction of various factors ranging from
neovascularization to collagenization to re-epithelialization.
There exists a delicate balance in between these successive
but overlapping phenomena and slight disturbance in this
balance can have a detrimental effect on wound healing.
Although a single gene may not be solely responsible for any
defect or impairment in healing as it is a very tightly
controlled and regulated process involving many gene
functions characterized by accurate and precise balance
between the inducers and inhibitors but an in-depth study of
these genes may provide an answer to the delayed healing in
impaired conditions.
MATERIALS AND METHODS
Animals
Female transgenic diabetic mice (BKS.Cg-mþ /þ Leprdbþ ), 8–10
weeks old, were obtained from Jackson Laboratories (Bar Harbor,
ME). These mice are homozygous for the diabetes spontaneous
mutation (Leprdb) and were chosen because they exhibit a series of
characteristics similar to those of human adult diabetes onset. The
metabolic abnormalities are result of a point mutation in the leptin
receptor gene (Lepr) on chromosome 4. We used homozygous
animals because only the homozygous animals develop diabetes,
whereas the heterozygous littermates show no signs of diabetes or
obesity. Blood glucose level of diabetic mice was 473714.06 mg/dl
and non-diabetic mice was 125.276.53 mg/dl (CVS/pharmacy
Complete Blood Glucose Monitoring System, Woonsocket, RI).
The animals were used in compliance with the US Public Health
Service policy on humane care and use of animals.
Creation of wounds
The animals were anesthetized using Nembutal sodium solution,
40 mg/kg, intraperitoneally (Abbott Lab, Chicago, IL). Hair on the
dorsal side of subjects was shaved and the skin was swabbed with
70% ethanol. An 8 mm skin biopsy punch (Acuderm Inc., Ft
Lauderdale, FL) was used to create full thickness cutaneous wounds
under aseptic conditions. Two wounds were created, one each on
the left and right sides of the midline. Thereafter, the animals were
individually caged.
Histopathological studies
Three animals from control and diabetic group were killed on the
4th, 7th, and 11th days after wounding, using Nembutal sodium
solution, 100 mg/kg, intraperitoneally, (Abbott Lab, Chicago, IL)
anesthesia. Wound tissues were excised in full depth to include
subcutaneous fat, including a margin of at least 5 mm of healthy
uninjured skin around each wound. Tissues were fixed in 10%
buffered neutral formalin, routinely processed, and embedded in
paraffin. At least three serial sections (5–6 mm) were stained with
hematoxylin and eosin for histological evaluation and morphometry.
Collagen was evaluated by the Masson’s trichrome stain.
Morphometric measurements and analysis
Morphometric measurement was made from sections through the
center of the wounds so as to obtain maximum wound diameter. The
measurements were performed three times, by studying the slides in
different random sequence, blinded to treatment. We counted the
number of vascular spaces in 10 high-power fields ( 20 objective),
midway in the wound bed. Dermal thickness was determined at the
center of each section, vertically, from the surface of granulation
tissue to the margin of dermis and subcutis. Wound width as a
measure of wound contraction was evaluated at the center of the
wound bed. Values obtained in treated and control groups were
compared and statistical analysis carried out using analysis of
variance (Abacus Concepts, Berkley, CA).
Total RNA preparation
Frozen tissues were minced over ice and transferred to 1.5 ml
microfuge tubes. Total RNA was extracted using TriZol kit
(Invitrogen Life Technologies, Carlsbad, CA) as per the manufac-
turer’s protocol. Total RNA was quantitated spectrophotometrically
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using Beckman DU640 Spectrophotometer (Beckman Instruments
Inc., Columbia, MD). RNA quality was determined electrophoreti-
cally using 1% agarose formaldehyde gel.
cDNA microarray
cDNA microarray was performed for the mouse angiogenesis panel
using a cDNA microarray kit (Superarray Bioscience Corporation,
Fredrick, MD) as per the manufacturer’s protocol. Briefly, procedure
can be divided into the following three parts: (I) probe synthesis (II)
hybridization, and (III) detection. Probe was synthesized using
True Labeling-RT kit (Superarray Bioscience Co., Fredrick, MD).
Prehybridization was performed for 2 hours followed by overnight
hybridization. Membranes were then washed and chemilumines-
cence was developed.
Image development and analysis. Images were developed by
exposing array membranes to the X-ray films (Kodak Scientific
Imaging Film, Eastern Kodak Company, Rochester, NY). Images were
scanned and analyzed using GEArray Expression Analysis Suite
software (SuperArray Biosciences Corp.). Background deduction was
carried out using the mean value of the negative controls
incorporated in the array. Internal normalization was carried out
using the mean value of the housekeeping genes, GAPDH.
RT-PCR for OPN
Expression of OPN mRNA was analyzed by RT-PCR. Reverse
transcription was performed using the first-strand synthesis kit
(Invitrogen Inc.) as per the manufacturer’s instruction. PCR was
performed using PCR supermix (Invitrogen Inc.) as per the
manufacturer’s protocol. Primers for PCR were: OPN sense primer
(50-AGTCGACATGAGATTGGCAGTGATTTGC-30), OPN antisence
primer (50-ACTCGAGGCCTCTTCTTTAGTTGACCTC-30). b-Actin
sense primer (50-ACCAACTGGGACGACATG-30), b-actin antisense
primer (50-AGAAGCACTTGCGGTGCACGAT-30) (Takahashi et al.,
2002). OPN cDNA amplification was performed according to the
following protocol: initial denaturation was performed at 951C for
3 minutes; then denaturation at 951C for 1 minute, annealing at 581C
for 45 seconds, extension at 721C for 1 minute, and 30 seconds for 35
cycles; a final extension was done at 721C for 7 minutes. b-Actin
cDNA amplification was performed according to the following
protocol: initial denaturation was done at 951C for 3 minutes; then
denaturation at 951C for 30 seconds, annealing at 551C for
45 seconds, extension at 721C for 1 minute for 35 cycles. PCR
product was visualized by electrophoreses on 1% agarose gel and
staining with ethidium bromide. Specific amplification was deter-
mined by comparing the size of product on gel relative to known
DNA molecular weight marker.
Immunohistochemical staining for OPN
Immunostaining was performed using monoclonal anti-OPN (Che-
micon International Inc., Temecula, CA) by an indirect avidin–biotin–
immunoperoxidase technique (Vectastain ABC Elite, Vector labora-
tories, Burlingame, CA) as specified by the manufacturer. Briefly,
sections were placed on poly-L-lysine-coated slides, deparaffinized,
and hydrated. Endogenous peroxidase activity was blocked with
hydrogen peroxide in methanol for 10 minute. Non-specific staining
was blocked with normal horse serum, and the sections were
incubated with monoclonal rat anti-human OPN (1:200) for
10–16 hours at 41C. To ascertain that the reaction of antibody was
specific, sections from each test were incubated with normal serum
IgG separately. Slides were washed with phosphate-buffered saline.
Biotinylated secondary antibody IgG (Hþ L) was added for
30 minutes, followed by avidin–biotin–peroxidase complex for
10 minutes. Slides were then stained with diaminobenzidine, and
counterstained with Harris hematoxylin and eosin.
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